What is Zoetis's cash & equivalents?

Zoetis (ZTS) reported cash & equivalents of $1.94B in Q1 2026.

How has Zoetis's cash & equivalents changed year-over-year?

Zoetis's cash & equivalents increased by 8.9% year-over-year, from $1.78B to $1.94B.

What is the long-term trend for Zoetis's cash & equivalents?

Over 5 years (2020 to 2025), Zoetis's cash & equivalents has grown at a -7.4% compound annual growth rate (CAGR), from $3.6B to $2.45B.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Zoetis ZTS Cash & Equivalents

Cash & Equivalents at other companies

Merck & Co.MRK

$5.4B-38.2%

NeogenNEOG

$159.9M+25.2%

Idexx LaboratoriesIDXX

$200.53M+22.3%

Phibro Animal HealthPAHC

$54.93M-9.0%

Elanco Animal Health Inc.ELAN

$428M-12.1%

Tractor Supply CompanyTSCO

$224.27M-3.2%

Other financials

Income statement

See full

Revenue$2.3B+2.9%

Gross profit$1.6B+2.6%

Net income$601.0M-0.2%

EPS (diluted)$1.42+6.0%

Balance sheet

See full

Total debt$10.0B+48.0%

Total equity$3.2B-30.5%

Total assets$15.2B+7.5%

Cash flow

See full

Operating cash flow$401.0M-22.1%

CapEx$110.0M-38.2%

Free cash flow$291.0M-13.6%

Valuation

See full

Market cap$31.9B-54.6%

Enterprise value$39.95B-47.2%

P/E12.1×-15.1×

P/S3.4×-4.1×

Profitability

See full

Gross margin71.8%+0.8pp

Net margin27.8%+0.9pp

FCF margin23.5%0.0pp

Returns & leverage

See full

Return on equity67%+15.8pp

Debt / equity3.1×+1.6×

Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zoetis's cash & equivalents?: Zoetis (ZTS) reported cash & equivalents of $1.94B in Q1 2026.
How has Zoetis's cash & equivalents changed year-over-year?: Zoetis's cash & equivalents increased by 8.9% year-over-year, from $1.78B to $1.94B.
What is the long-term trend for Zoetis's cash & equivalents?: Over 5 years (2020 to 2025), Zoetis's cash & equivalents has grown at a -7.4% compound annual growth rate (CAGR), from $3.6B to $2.45B.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.